Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
CNS disorder biotech Alto Neuroscience sets terms for $101 million IPO
Renaissance Capital
Mon, 01/29/24 - 11:12 am
Alto Neuroscience
IPOs
biomarkers
depression schizophrenia
ArriVent takes in $175M from second biotech IPO of the year
Fierce Biotech
Fri, 01/26/24 - 11:17 am
ArriVent Biopharma
IPOs
furmonertinib
China
non-small cell lung cancer
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology
2024 Brings Surprising Early Surge of Biotech IPOs
BioSpace
Fri, 01/19/24 - 09:43 am
biotech
IPOs
CG Oncology
Alto Neuroscience
ArriVent Biopharma
Kyverna Therapeutics
Metagenomi
CG Oncology aims for $209M IPO, as more biotechs eye path to public markets
Fierce Biotech
Thu, 01/18/24 - 11:11 am
CG Oncology
IPOs
oncology
bladder cancer
For biotech dealmakers, it’s everything, everywhere all at once
Fierce Biotech
Wed, 01/17/24 - 09:40 am
M&A
IPOs
reverse merger
venture capital
Alto Neuroscience preps IPO to push precision psychiatry therapies through the clinic
Fierce Biotech
Tue, 01/16/24 - 09:54 am
Alto Neuroscience
machine learning
artificial intelligence
IPOs
depression
Cancer biotech ArriVent Biopharma files for a $100 million IPO
Renaissance Capital
Mon, 01/8/24 - 11:38 am
ArriVent Biopharma
IPOs
cancer
Gene editing startup Metagenomi files for an IPO
BioPharma Dive
Sun, 01/7/24 - 04:16 pm
Metagenomi
CRISPR
IPOs
gene editing
CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout
Fierce Biotech
Wed, 01/3/24 - 09:35 am
CG Oncology
IPOs
bladder cancer
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Tue, 12/19/23 - 11:42 am
biotech
IPOs
Cargo Therapeutics
Lexeo Therapeutics
RazyeBio
Abivax
Neumora Therapeutics
Fractyl, hoping its GLP-1 gene therapy can take on Wegovy, plans IPO
Fierce Biotech
Fri, 12/15/23 - 09:41 am
Fractyl Health
IPOs
Novo Nordisk
Wegovy
GLP-1 agonist
Chinese biotech firm HighTide Therapeutics slashes Hong Kong IPO size by 80% to US$35.6 million
Yahoo/South China Morning Post
Thu, 12/14/23 - 09:44 am
HighTide Therapeutics
IPOs
Hong Kong
Biopharma’s top 5 IPOs of 2023 (so far)
Pharma Voice
Thu, 11/30/23 - 10:01 am
biotech
IPOs
Acelyrin
Apogee Therapeutics
RayzeBio
Neumora Therapeutics
Mineralys Therapeutics
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
BioSpace
Mon, 11/20/23 - 10:07 am
Carmot Therapeutics
obesity
IPOs
WuXi Biologics bioconjugates spinout plans $470 million IPO
Biopharma Reporter
Thu, 11/9/23 - 11:30 pm
WuXi Biologics
IPOs
spinoffs
WuXi XDC
CRDMOs
IPO Update: Cargo Therapeutics Readies Plans For $300 Million IPO
Seeking Alpha
Mon, 11/6/23 - 07:21 pm
Cargo Therapeutics
IPOs
large B cell lymphoma
WuXi Biologics' medical research unit eyes up to $471 million in Hong Kong IPO
Reuters
Mon, 11/6/23 - 07:15 pm
WuXi XDC
IPOs
Hong Kong
WuXi Biologics
Lexeo drops share price at last minute in attempt to raise $100M IPO
Fierce Biotech
Fri, 11/3/23 - 11:53 am
Lexeo Therapeutics
IPOs
gene therapy
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
BioPharma Dive
Fri, 10/27/23 - 11:39 am
biotech
funding
IPOs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »